Bortezomib/dexamethasone versus VAD as induction prior to autologous stem cell transplantion (ASCT) in previously untreated multiple myeloma (MM): Updated data from IFM 2005/01 trial
暂无分享,去创建一个
P. Moreau | H. Avet-Loiseau | G. Marit | C. Mathiot | T. Facon | J. Harousseau | M. Attal | D. Caillot | I. Webb | Cyrille Hullin